<table className="table"><caption><p>American Cancer Society Recommendations for MRI Breast Cancer Screening</p></caption><tbody><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Women with <i>BRCA1/2</i> pathogenic variants</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Women who are a first-degree relative of a <i>BRCA1/2</i> carrier but are untested<sup>a</sup></p></td></tr><tr className="group_1-3 row-odd"><td colSpan="1" rowSpan="1"><p>Women with a strong family history of breast cancer with a lifetime breast cancer risk of â‰¥20% to 25% as calculated by models<sup>b</sup> largely dependent on family history</p></td></tr><tr className="group_1-4 row-even"><td colSpan="1" rowSpan="1"><p>Women who had radiation to the chest wall between ages 10 and 30 years (e.g., mantle radiation therapy for Hodgkin lymphoma)</p></td></tr><tr className="group_1-5 row-odd"><td colSpan="1" rowSpan="1"><p>Women with a history of other rare familial breast cancer syndromes</p></td></tr></tbody></table>